fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
Published 6 years ago • 163 plays • Length 13:36
Download video MP4
Download video MP3
Similar videos
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
6:48
fda approval in prostate cancer, phase iii data in breast cancer, and more
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
11:13
fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
7:52
emerging strategies in cll and folicular lymphoma
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
1:01:48
update on oral therapies in lymphoma and cll | lrf webinars
-
11:34
fda approval in cll, recommendation in sts, partial hold on cervical cancer trial, and more
-
0:31
preview: fda approvals in cll and all, nda accepted in melanoma, and more
-
3:31
fda investigating possible increased risk of death with lymphoma medicine ukoniq (umbralisib)
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
Clip.africa.com - Privacy-policy